Literature DB >> 17681056

Management of extrinsic malignant ureteral obstruction with urinary diversion.

Takehiro Kanou1, Chisato Fujiyama, Kazushige Nishimura, Yuji Tokuda, Jiro Uozumi, Zenjiro Masaki.   

Abstract

OBJECTIVE: The effectiveness of urinary diversion for patients with renal insufficiency due to extrinsic ureteral obstruction was assessed.
METHODS: Between 1990 and 2003, 30 males and 45 females, ranging 36-90 years of age (average, 62.7) who had secondary ureteral obstruction due to either a retroperitoneal or pelvic invasion of malignant disease, underwent nephrostomy or ureteral stenting using a double-J stent without side holes.
RESULTS: Ureteral stenting was attempted as an initial procedure in 51 of the 75 cases. The remaining 24 cases had a nephrostomy at the first step. Of 51, 37 cases were successfully stented, while internal stenting was unsuccessful in the remaining 14 cases. These 14 cases were treated with nephrostomy at the second step following the unsuccessful internal stenting. Eight cases of the 37 successfully stented cases were eventually changed to a nephrostomy because of catheter trouble. As a result, 29 cases could be managed by internal ureteral stenting up until the end of their life. The follow-up period for the 75 cases who underwent urinary diversion ranged from 5 days to 19 months, averaging 5.7 months. The average period from diversion to death was 5.6 months in the internally stented group and 5.9 months in the nephrostomy group.
CONCLUSION: The high patency rate of the internal ureteral stent in our cases might be due to our use of a stent without shaft vent holes.

Entities:  

Mesh:

Year:  2007        PMID: 17681056     DOI: 10.1111/j.1442-2042.2007.01747.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  13 in total

Review 1.  Use of percutaneous nephrostomy and ureteral stenting in management of ureteral obstruction.

Authors:  Linda Hsu; Hanhan Li; Daniel Pucheril; Moritz Hansen; Raymond Littleton; James Peabody; Jesse Sammon
Journal:  World J Nephrol       Date:  2016-03-06

2.  Outcomes of Ureteral Stent Placement for Hydronephrosis in Patients with Gynecological Malignancies.

Authors:  Saya Kurata; Shohei Tobu; Kazuma Udo; Mitsuru Noguchi
Journal:  Curr Urol       Date:  2017-07-30

3.  Predicting the failure of retrograde ureteral stent insertion for managing malignant ureteral obstruction in outpatients.

Authors:  Jin-You Wang; Hai-Liang Zhang; Yao Zhu; Xiao-Jian Qin; B O Dai; Ding-Wei Ye
Journal:  Oncol Lett       Date:  2015-11-24       Impact factor: 2.967

Review 4.  Palliative management of malignant upper urinary tract obstruction.

Authors:  P Sountoulides; I Mykoniatis; N Dimasis
Journal:  Hippokratia       Date:  2014 Oct-Dec       Impact factor: 0.471

5.  Percutaneous antegrade ureteral stent placement: single center experience.

Authors:  Güven Kahriman; Nevzat Özcan; Aytaç Doğan; Hakan İmamoğlu; Abdullah Demirtaş
Journal:  Diagn Interv Radiol       Date:  2019-03       Impact factor: 2.630

6.  Antegrade double-J stent placement for the treatment of malignant obstructive uropathy: A retrospective cohort study.

Authors:  Ghassen Tlili; Houssem Ammar; Sonia Dziri; Khaled Ben Ahmed; Waad Farhat; Sofiene Arem; Emir Acacha; Rahul Gupta; Arib Rguez; Mehdi Jaidane
Journal:  Ann Med Surg (Lond)       Date:  2021-08-16

7.  Gastrointestinal cancer and bilateral hydronephrosis resulted in a high risk of ureteral stent failure.

Authors:  Mari Ohtaka; Takashi Kawahara; Daiji Takamoto; Taku Mochizuki; Yusuke Hattori; Jun-Ichi Teranishi; Kazuhide Makiyama; Yasuhide Miyoshi; Yasushi Yumura; Masahiro Yao; Hiroji Uemura
Journal:  BMC Urol       Date:  2018-05-08       Impact factor: 2.264

8.  Retrograde pyelography predicts retrograde ureteral stenting failure and reduces unnecessary stenting trials in patients with advanced non-urological malignant ureteral obstruction.

Authors:  Sung Han Kim; Boram Park; Jungnam Joo; Jae Young Joung; Ho Kyung Seo; Jinsoo Chung; Kang Hyun Lee
Journal:  PLoS One       Date:  2017-09-20       Impact factor: 3.240

9.  Antegrade double-J stenting as an alternative to the retrograde approach: experience of the first 150 cases at a single center in Brazil.

Authors:  Renata Motta Grubert; Carlos Egydio Ferri do Carmo; Reinaldo Santos Morais Neto; Tiago Kojun Tibana; Rômulo Florêncio Tristão Santos; Edson Marchiori; Thiago Franchi Nunes
Journal:  Radiol Bras       Date:  2021 Nov-Dec

10.  Percutaneous nephrostomy versus antegrade double-J stent placement in the treatment of malignant obstructive uropathy: a cost-effectiveness analysis from the perspective of the Brazilian public health care system.

Authors:  Tiago Kojun Tibana; Renata Motta Grubert; Rômulo Florêncio Tristão Santos; Vinicius Adami Vayego Fornazari; André Alonso Domingos; William Tavares Reis; Edson Marchiori; Thiago Franchi Nunes
Journal:  Radiol Bras       Date:  2019 Sep-Oct
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.